Overview
- The executive order, signed on Aug. 10, directs HHS to narrow routine childhood vaccine recommendations and to pursue splitting the combined MMR vaccine into separate measles, mumps and rubella shots.
- Major medical groups, public-health officials and cancer and nursing organizations immediately condemned the move as unscientific and said it could increase vaccine hesitancy and outbreak risk during a large U.S. measles surge.
- Industry and former regulators say there are no licensed single-antigen MMR products in the United States and that rebuilding separate vaccines and gaining FDA approval would likely take years and substantial investment.
- The order tells the Justice Department to press states that do not follow the guidance, prompting state attorneys general and multistate coalitions to prepare litigation and governors to publicly defend existing school-entry rules.
- Practical effects are already reported at the local level with school nurses and clinicians facing confusion and extra workload, and experts warn more clinic visits and missed follow-ups could lower completion rates for childhood immunizations.